Mitchell & Pahl Private Wealth, LLC Biogen Inc. Transaction History

Mitchell & Pahl Private Wealth, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 25, 2022	SELL	$187.54 - $223.02 $43,321 - $51,517	-231 Reduced 13.93%	1,427 $291,000
Q1 2022 Apr 14, 2022	SELL	$193.77 - $244.14 $5,813 - $7,324	-30 Reduced 1.78%	1,658 $349,000
Q4 2021 Jan 19, 2022	SELL	$223.92 - $287.77 $81,059 - $104,172	-362 Reduced 17.66%	1,688 $405,000
Q3 2021 Nov 03, 2021	SELL	$282.99 - $369.05 $4,810 - $6,273	-17 Reduced 0.82%	2,050 $580,000
Q2 2021 Jul 14, 2021	SELL	$259.0 - $414.71 $4,921 - $7,879	-19 Reduced 0.91%	2,067 $716,000
Q1 2021 Apr 29, 2021	SELL	$242.95 - $284.63 $1,457 - $1,707	-6 Reduced 0.29%	2,086 $584,000
Q4 2020 Feb 09, 2021	BUY	$236.26 - $355.63 $494,255 - $743,977	2,092 New	2,092 $512,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Mitchell & Pahl Private Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Mitchell & Pahl Private Wealth, LLC with notifications on news.